315 related articles for article (PubMed ID: 30408543)
21. Targeting epigenetic modifications in Parkinson's disease therapy.
Zhang D; Zhang J; Wang Y; Wang G; Tang P; Liu Y; Zhang Y; Ouyang L
Med Res Rev; 2023 Sep; 43(5):1748-1777. PubMed ID: 37119043
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
23. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
24. Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy.
Maemoto Y; Shimizu Y; Katoh R; Ito A
J Antibiot (Tokyo); 2021 Oct; 74(10):667-676. PubMed ID: 34426659
[TBL] [Abstract][Full Text] [Related]
25. Curcumin as a regulator of epigenetic events.
Teiten MH; Dicato M; Diederich M
Mol Nutr Food Res; 2013 Sep; 57(9):1619-29. PubMed ID: 23754571
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic effects of nano-sized materials.
Stoccoro A; Karlsson HL; Coppedè F; Migliore L
Toxicology; 2013 Nov; 313(1):3-14. PubMed ID: 23238276
[TBL] [Abstract][Full Text] [Related]
27. The Role of Diazepam in Epigenetics: From the Molecular Level to Clinical Implications.
Pathak S; Gupta G; Gilhotra RM
Adv Mind Body Med; 2021 Winter; 35(1):25-33. PubMed ID: 33513583
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases.
Vendetti FP; Rudin CM
Expert Opin Biol Ther; 2013 Sep; 13(9):1273-85. PubMed ID: 23859704
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
30. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M
Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000
[TBL] [Abstract][Full Text] [Related]
32. Natural Products Impacting DNA Methyltransferases and Histone Deacetylases.
Akone SH; Ntie-Kang F; Stuhldreier F; Ewonkem MB; Noah AM; Mouelle SEM; Müller R
Front Pharmacol; 2020; 11():992. PubMed ID: 32903500
[TBL] [Abstract][Full Text] [Related]
33. Dual targeting of epigenetic therapy in cancer.
Hellebrekers DM; Griffioen AW; van Engeland M
Biochim Biophys Acta; 2007 Jan; 1775(1):76-91. PubMed ID: 16930846
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic and disease targets by polyphenols.
Pan MH; Lai CS; Wu JC; Ho CT
Curr Pharm Des; 2013; 19(34):6156-85. PubMed ID: 23448446
[TBL] [Abstract][Full Text] [Related]
35. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Regulatory Mechanisms Induced by Resveratrol.
Fernandes GFS; Silva GDB; Pavan AR; Chiba DE; Chin CM; Dos Santos JL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29104258
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional Selectivity of Epigenetic Therapy in Cancer.
Sato T; Cesaroni M; Chung W; Panjarian S; Tran A; Madzo J; Okamoto Y; Zhang H; Chen X; Jelinek J; Issa JJ
Cancer Res; 2017 Jan; 77(2):470-481. PubMed ID: 27879268
[TBL] [Abstract][Full Text] [Related]
38. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.
Rastgoo N; Abdi J; Hou J; Chang H
J Hematol Oncol; 2017 Jun; 10(1):121. PubMed ID: 28623912
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
Yuan Z; Sun Q; Li D; Miao S; Chen S; Song L; Gao C; Chen Y; Tan C; Jiang Y
Eur J Med Chem; 2017 Jul; 134():281-292. PubMed ID: 28419930
[TBL] [Abstract][Full Text] [Related]
40. Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.
Hodjat M; Rahmani S; Khan F; Niaz K; Navaei-Nigjeh M; Mohammadi Nejad S; Abdollahi M
Arch Toxicol; 2017 Jul; 91(7):2577-2597. PubMed ID: 28516248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
